ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Specialist

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

15,730Medicare Part D Prescriptions Filled, Including Refills

Rank: 23 out of 1571

$949K Total Retail Price of All Prescriptions

Rank: 68 out of 1571

946 Patients Receiving at Least One Drug in Part D
74%Patients 65 Years and Older
63% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in California
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 946 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

12% of this provider’s 946 patients filled at least one prescription for a schedule three drug, compared to an average of 13%.

Risky Drugs to Seniors

3% of this provider’s 12,629 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 29%.

Prescription Price

$60 was the average price of a prescription from this provider, compared to $99 among peers.

Prescriptions per Patient

17 is the average number of prescriptions (including refills) per patient, compared to an average of 11.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in California
OMEPRAZOLE 740 477 1 4
AMLODIPINE BESYLATE 601 535 2 2
LEVOTHYROXINE SODIUM 581 515 3 6
HYDROCODONE-ACETAMINOPHEN 568 372 S3 4 3
FUROSEMIDE 513 456 5 7
METOCLOPRAMIDE HCL 323 236 6 116
ATORVASTATIN CALCIUM 300 273 7 8
SIMVASTATIN 295 244 8 1
LISINOPRIL 288 252 9 5
ATENOLOL 282 245 10 15
METFORMIN HCL 280 221 11 9
PANTOPRAZOLE SODIUM 267 233 12 23
DONEPEZIL HCL 247 247 13 24
KLOR-CON 8 223 211 14 152
MELOXICAM 216 195 15 49
CARVEDILOL 213 180 16 10
ZOLPIDEM TARTRATE 196 141 17 20
PEG-3350 AND ELECTROLYTES 177 123 18 230
LEVOFLOXACIN 154 119 19 79
QUETIAPINE FUMARATE 152 152 20 102
POTASSIUM CHLORIDE 151 132 21 27
DIOVAN 142 139 22 19
DICYCLOMINE HCL 141 114 23 216
LANTUS 135 105 24 65
RANITIDINE HCL 134 89 25 85
HYDROCHLOROTHIAZIDE 132 127 26 18
DIGOXIN 130 117 27 35
GABAPENTIN 129 107 28 12
TAMSULOSIN HCL 128 119 29 11
WARFARIN SODIUM 128 111 29 14
TAMIFLU 126 125 31 504
METOPROLOL TARTRATE 124 116 32 13
NAMENDA 116 116 33 37
PRAVASTATIN SODIUM 115 109 34 26
NEXIUM 115 89 34 39
BENAZEPRIL HCL 107 88 36 32
CARISOPRODOL 107 73 R 36 80
FLUOXETINE HCL 104 93 38 112
FAMOTIDINE 102 65 39 54
PREDNISONE 101 83 40 34
CELEBREX 97 97 41 71
AMITRIPTYLINE HCL 96 78 R 42 117
ONDANSETRON HCL 95 0 43 301
AMLODIPINE BESYLATE-BENAZEPRIL 95 83 43 135
CIPROFLOXACIN HCL 93 55 45 38
SERTRALINE HCL 92 70 46 52
ENALAPRIL MALEATE 89 88 47 81
TRAMADOL HCL 86 64 48 31
KLOR-CON 10 86 86 48 223
RISPERIDONE 84 72 50 89
PROMETHAZINE HCL 83 25 R 51 351
SPIRONOLACTONE 72 38 52 69
SYNTHROID 71 71 53 59
IBUPROFEN 71 52 53 44
SULFAMETHOXAZOLE-TRIMETHOPRIM 71 54 53 86
POLYETHYLENE GLYCOL 3350 70 47 56 146
AVODART 68 68 57 40
METHADONE HCL 68 11 S2 57 153
ALENDRONATE SODIUM 66 66 59 22
CITALOPRAM HBR 65 46 60 66
METOPROLOL SUCCINATE 64 49 61 16
LANTUS SOLOSTAR 63 54 62 149
LOSARTAN POTASSIUM 63 63 62 17
GLIPIZIDE 63 47 62 53
COLESTIPOL HCL 62 59 65 522
DETROL LA 60 60 66 246
MIRTAZAPINE 59 28 67 96
DIPHENOXYLATE-ATROPINE 58 40 68 361
GLYBURIDE 57 43 R 69 99
AZITHROMYCIN 57 43 69 58
GEMFIBROZIL 57 39 69 142
TRIAMTERENE-HCTZ 55 48 72 97
DEXILANT 53 52 73 91
ALLOPURINOL 53 53 73 36
HYDROXYZINE HCL 53 33 R 73 207
VANCOMYCIN HCL 50 0 76 535
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 16, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.